Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Cytokinetics Still Has Value, Despite Setbacks
Cytokinetics Still Has Value, Despite Setbacks
Cytokinetics Still Has Value, Despite Setbacks
Submitted by
admin
on May 8, 2014 - 8:28am
Source:
Seeking Alpha
News Tags:
Cytokinetics
Omecamtiv Mecarbil
Tirasemtiv
Headline:
Cytokinetics Still Has Value, Despite Setbacks
Do Not Allow Advertisers to Use My Personal information
